Clinical Research Directory
Browse clinical research sites, groups, and studies.
Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
Sponsor: Umeå University
Summary
de Novo metastatic prostate cancer with limited metastatic spread benefits from local radiotherapy to the prostate. Two different fractionation schedules will be tested.
Official title: A Randomized Phase III, Multicenter Study to Evaluate Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
420
Start Date
2022-10-31
Completion Date
2032-09-30
Last Updated
2024-02-28
Healthy Volunteers
No
Interventions
Moderate hypo-fractionation
Patients will receive four weeks of radiotherapy
Ultra-hypo-fractionation
Patients will receive two and a half weeks of radiotherapy
Locations (1)
Cancercenter University hospital of Umeå
Umeå, Sweden